This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 October 2024, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

News

Subpage Hero

     

Update to Abbott’s FreeStyle LibreLink App** Enables People Using The FreeStyle Libre 2 system to Receive Automatic Glucose Readings Every Minute*

Update to Abbott’s FreeStyle LibreLink App** Enables People Using The FreeStyle Libre 2 system to Receive Automatic Glucose Readings Every Minute*

Images are for illustration purposes. Not actual patient or data.

The latest FreeStyle LibreLink app update, available now on the Apple App Store or Google Play Store, allows people in the UK and Ireland who use Abbott’s FreeStyle Libre 2 system to receive glucose readings every minute automatically* sent to their phone**. This latest update means there is no need to regularly scan sensors. Instead, glucose readings every minute will now automatically be displayed on the FreeStyle LibreLink app in real-time*, so users can effortlessly know where their glucose levels are and where they are headed with a quick glance of their smartphone.**

Having glucose readings every minute will enable people to manage their diabetes even more confidently,⁷ allowing them to recognise a change in their glucose levels sooner and act faster to avoid potential issues like hypoglycaemia or extremely low glucose. Effective monitoring and management of diabetes is crucial as studies have shown that proper glucose control can help decrease diabetes-related complications and increase life expectancy for people living with diabetes.¹,²,³. There are also positive ramifications for family members and those who are involved in the management of someone’s diabetes. The new feature also allows parents and caregivers of people using the FreeStyle Libre 2 system and the app, to automatically receive glucose readings every minute and customised alarms⁸ through the LibreLinkUp caregiver app, helping to provide further peace of mind.⁴ *** LibreLinkUp users who wish to receive real-time glucose readings from their connections who are using FreeStyle Libre 2 sensors must update their LibreLinkUp app to version 4.7 and higher.

Lynn Whitworth, who lives with Type 2 diabetes said: “Having such a straightforward way to monitor my glucose levels provides me with all the information I need to make confident decisions around the management of my diabetes. I can automatically see the impact that various choices I make throughout the day have on my glucose levels, and all without scanning or finger-pricking.”†

The impact of the app update could be far reaching as, according to Diabetes UK, the number of adults living with diabetes in the UK is estimated to be around more than 5 million, of which 90% are adults living with Type 2 diabetes.⁵  Among those living with Type 2 diabetes, clinical experts predict that uptake of Continuous Glucose Monitors, or CGM, will rise to 70% by 2026/27. It also estimated that 28% of children and young people living with diabetes are using real-time continuous monitoring which is also expected to rise to 55% by 2026/27. ⁶

Visit FreeStyle.Abbott to find out how the FreeStyle Libre 2 system can help your patients manage their diabetes more confidently.⁷

*Glucose readings are automatically displayed in the FreeStyle LibreLink app only when user's smartphone and sensor are connected and in range.

**The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

References

1. JDRF, 2022. Type 1 Diabetes Index. https://www.t1dindex.org/countries/the-united-kingdom/ Last accessed: September 2023.

2. DCCT Research Group. N Engl J Med 1993;329:977–986.

3. UKPDS. Lancet 1998;352:837–853.

4. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142

5. Diabetes UK. Number of people living with diabetes in the UK tops 5 million for the first time 2023. Accessed at: https://www.diabetes.org.uk/about_us/news/number-people-living-diabetes-uk-tops-5-million-first-time#:~:text=Our%20new%20figures%20show%20that,2%20diabetes%20in%20the%20UK Last accessed: September 2023.

6. National Institute for Health and Care Excellence. Resource impact report for continuous glucose monitoring recommendations in: Type 1 diabetes in adults: diagnosis and management (NG17) Type 2 diabetes in adults: management (NG28) Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18). 2022. Accessed at: https://www.nice.org.uk/guidance/ng28/resources/resource-impact-report-type-1-and-type-2-diabetes-and-continuous-glucose-monitoring-pdf-11020390813 Last accessed: September 2023.

7. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809

8. The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users

***The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.

ADC-85435 v1.0 01/24

© 2024 Abbott. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. ADC-85435 v1.0 01/24.

View all News
Loading

Sponsors

Diamond sponsor

 

Gold sponsor

Gold sponsor

Gold sponsor

Partners

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner